ShockWave Medical, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SWAV research report →
Companywww.shockwavemedical.com
ShockWave Medical, Inc. , a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD.
- CEO
- Douglas E. Godshall
- IPO
- 2019
- Employees
- 1,468
- HQ
- Santa Clara, CA, US
Price Chart
Valuation
- Market Cap
- $12.57B
- P/E
- 83.43
- P/S
- 17.21
- P/B
- 18.38
- EV/EBITDA
- 68.17
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 86.94%
- Op Margin
- 22.73%
- Net Margin
- 20.17%
- ROE
- 24.96%
- ROIC
- 9.57%
Growth & Income
- Revenue
- $730.23M · 49.11%
- Net Income
- $147.28M · -31.81%
- EPS
- $4.01 · -33.39%
- Op Income
- $165.99M
- FCF YoY
- 78.67%
Performance & Tape
- 52W High
- $334.90
- 52W Low
- $157.00
- 50D MA
- $325.08
- 200D MA
- $240.56
- Beta
- 0.88
- Avg Volume
- 1.25M
Get TickerSpark's AI analysis on SWAV
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 31, 24 | FRANCIS LAURA | sell | 3,551 |
| May 31, 24 | FRANCIS LAURA | sell | 13,690 |
| May 31, 24 | MOLL FREDERIC H | sell | 16,393 |
| May 31, 24 | MOLL FREDERIC H | sell | 17,381 |
| May 31, 24 | MOLL FREDERIC H | sell | 287,521 |
| May 31, 24 | Papiernik Antoine | sell | 736 |
| May 31, 24 | Sainz Maria | sell | 5,328 |
| May 31, 24 | Toyloy Sara | sell | 3,673 |
| May 31, 24 | WATKINS FRANK T | sell | 84,313 |
| May 31, 24 | WATKINS FRANK T | sell | 17,381 |
Our SWAV Coverage
We haven't published any research on SWAV yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SWAV Report →